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Abstract 
 
       This study was carried out in Khartoum state during 
period between January .2005 to September .2007. 
       The study evaluates the potency of third generation 
Cephalosporins  
(Ceftazidime, Ceftriaxone, Cefotaxime, Cefoperazone) 
against clinical isolates recovered from wounds infection 
caused by bacteria. 
      Specimens were collected from different hospitals 
including Khartoum Teaching Hospital, Al Amal National 
Hospital and National Health Laboratory. 
     Different types of bacteria were isolated including 
Staphylococcus aureus 55, pseudomonas aeruginosa 45, 
Escherichia coli 28, Proteus vulgaris 25, Klebsiella 
Pneumoniae 20.      
      The result also indicated that the organisms isolated from 
males and females were 65% and 35% respectively. 
        The study showed that Ceftazidime was most effective 
followed by Cefoperazone, Ceftriaxone and Cefotaxime.  
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   ﺍﻟﻤﺴﺘﺨﻠﺹ
 ﺤﺘﻰ  ﺴﺒﺘﻤﺒﺭ 5002ﺘﻡ ﺘﻨﻔﻴﺫ ﻫﺫﺓ ﺍﻟﺩﺭﺍﺴﺔ  ﻓﻰ ﻭﻻﻴﺔ ﺍﻟﺨﺭﻁﻭﻡ ﻓﻰ ﺍﻟﻔﺘﺭﺓ ﻤﻥ ﻴﻨﺎﻴﺭ 
) ﻡ ، ﺘﻨﺎﻭﻟﺕ ﺍﻟﺩﺭﺍﺴﺔ ﺘﻘﻴﻴﻡ ﻓﺎﻋﻠﻴﺔ ﺍﻟﻤﺠﻤﻭﻉ ﺍﻟﺜﺎﻟﺜﺔ ﻤﻥ ﻤﻀﺎﺩﺍﺕ ﺍﻟﺴﻔﺎﻟﻭﺴﺒﻭﺭﻴﻨﺎﺕ 7002
ﻟﻌﻼﺝ ﺍﻟﺘﻬﺎﺒﺎﺕ ﺍﻟﺠﺭﻭﺡ  ( ﺍﻟﺴﻴﻔﺎﺯﺩﻴﻡ ، ﺍﻟﺴﻴﻔﺘﺭﺍﻴﻜﺴﻭﻥ، ﺍﻟﺴﻴﻔﻭﺘﺎﻜﺴﻴﻡ،ﺍﻟﺴﻴﻔﻭﺒﻴﺭﺍﺯﻭﻥ
  .ﻁﺔ ﺍﻟﺒﺎﻜﺘﺭﻴﺎﺍﻟﻤﺴﺒﺒﺔ ﺒﻭﺍﺴ
ﺘﻡ ﺠﻤﻊ ﻋﻴﻨﺎﺕ ﻁﺒﻴﺔ ﻤﻥ ﻋﺩﻩ ﻤﺴﺘﺸﻔﻴﺎﺕ ﺸﻤﻠﺕ ﻤﺴﺘﺸﻔﻰ ﺍﻟﺨﺭﻁﻭﻡ ﺍﻟﺘﻌﻠﻴﻤﻰ ﻭﻤﺴﺘﺸﻔﻰ 
  .ﺍﻻﻤل ﺍﻟﻭﻁﻨﻰ ﻭﺍﻟﻤﻌﻤل ﺍﻟﻘﻭﻤﻰ ﺍﻟﺼﺤﻰ
 ﺴﻼﻟﻪ ﻭﺍﻟﺯﺍﺌﻔﻪ 55ﺘﻡ ﻋﺯل ﻭﺘﺤﺩﻴﺩ ﺍﻨﻭﺍﻉ ﻤﺨﺘﻠﻔﻪ ﻤﻥ ﺍﻟﺒﺎﻜﺘﺭﻴﺎ ﺸﻤﻠﺕ ﺍﻟﻌﻨﻘﻭﺩﻴﺔ ﺍﻟﺫﻫﺒﻴﺔ 
 ﺴﻼﻟﻪ 52 ﻠﺒﻪ ﺍﻻﻋﺘﻴﺎﺩﻴﺔﺍﻟﻤﺘﻘ ﺴﻼﻟﻪ ﻭ82 ﺴﻼﻟﻪ ﻭﺍﻻﺸﺭﻴﻜﻴﺔ ﺍﻟﻘﻭﻟﻭﻨﻴﺔ 54ﺍﻟﺯﻨﺠﺎﺭﻴﺔ 
  . ﺴﻼﻟﻪ02ﻭﺍﻟﻜﻠﺒﺴﻴﻼ ﺍﻟﺭﺌﻭﻴﻪ 
ﻭﺍﻻﻨﺎﺙ % 56ﺍﻟﻨﺘﺎﺌﺞ ﺍﻴﻀﺎ ﺍﺸﺎﺭﺕ ﺍﻟﻰ ﺍﻥ  ﺍﻟﻤﻴﻜﺭﻭﺒﺎﺕ ﺍﻟﻤﻌﺯﻭﻟﻪ ﻤﻥ ﺍﻟﺫﻜﻭﺭ ﻫﻰ 
 . ﺍﻟﺘﻭﺍﻟﻰﻋﻠﻰ% 53
ﻟﻘﺩ ﺘﻭﺼﻠﺕ ﺍﻟﺩﺭﺍﺴﻪ ﺍﻟﻰ ﺍﻥ ﺍﻟﺴﻴﻔﺎﺯﺩﻴﻡ ﻫﻭ ﺍﻜﺜﺭ ﺍﻟﻤﻀﺎﺩﺍﺕ  ﺍﻟﺤﻴﻭﻴﺔ ﻜﻔﺎﺀﺓ ﻴﺘﺒﻌﻪ 
  .ﻔﻭﺘﺎﻜﺴﻴﻡﺍﻟﺴﻴﻔﻭﺒﻴﺭﺍﺯﻭﻥ، ﺍﻟﺴﻴﻔﺘﺭﺍﻴﻜﺴﻭﻥ ﻭﺍﺨﻴﺭﺍ ﺍﻟﺴﻴ
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Chapter One 
1- Introduction and Literature Review 
1.1 Infection: 
1. 1.1 Definition:  
Infection is the mechanism through which microbial agents reach 
their potential victims and elicit pathogenic reactions (Elegail, 1994). 
When a microorganism or an infectious agent invades a human or animal 
body and disease results, whether clinical or sub-clinical, the process is 
called infection. The microorganism is called a parasite, and the human or 
animal body is referred to as the host.  
The presence of a pathogenic microorganism in or about the body of the 
host does not alone suffice to produce the interaction referred to as 
infection.  
There for infection is the interaction between a host and a parasite in an 
environment common to and affecting both  
(Infection = host + parasite + environment).  
Infection, whether clinically recognizable (apparent) or not recognizable 
(inapparent or subclinical), cannot occur without a host and a parasite and 
the environment (Elegail, 1994) 
1.1.2 Effects of Infection: 
The infections that matter are those causing pathological changes 
and disease. Many infectious agents cause little or no damage in the host. 
19 
 
Indeed it’s of some infections advantage to the microorganism to cause 
minimal host damage.  
When bacteria invade tissues, they almost inevitably cause some 
damage, and this is also true for fungi, protozoa, and rickettsia. The 
extent of direct damage however is sometimes slight. This is true for 
Treponema pallidum which produces no potent toxins and attaches to cell 
in vitro without harmful effects. Leprosy and tubercle bacilli eventually 
damage and kill the macro-phages in which they replicate, but 
pathological changes are to a large extent caused by indirect mechanisms 
(Mims, 1982). 
1.1.3 Infectivity: 
The infectivity of an organism is its pathogenic potential. This 
includes successful entry to the body, establishment in the tissues and 
exertion of its pathogenic effects through invasiveness, toxigenicity or a 
combination of both (Ross, 1979). 
1.1.4 The. Infectious Process: 
Infection Indicates multiplication of bacteria. Prior to 
multiplication, bacteria must enter and establish themselves within the 
host. Once in the body, bacteria must attach or adhere to host cells, 
usually epithelial cells. After the bacteria have established a primary site 
of infection, they multiply and spread. 
Infection can spread directly through tissues or via the lymphatic 
system to the blood stream. Blood stream infection (bacteraemia) can be 
transient or persistent. Bacteraemia allows bacteria to spread widely in 
the body and permits them to reach tissues particularly suitable for their 
multiplication (Jawetz et al. 1991). 
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1.1.5 Sources of Infection: 
The terms source, reservoir and vehicle of infection are frequently 
confused and misused. Source refers to the habitat or growth area in the 
human or animal. Reservoir and vehicle refer to objects that are 
contaminated or colonized by microorganisms. Animals are also sources 
of infection that may be transmitted to man; such infections are known as 
zoonosis (Ross, 1979). 
Infections may be classified according to their sources into: 
1. 1.5. 1 Endogenous Infection: 
 (Autogenous Infections): 
Endogenous infections are contracted from the host himself. Many 
areas of the body have a normal, commensal flora characteristic of the 
particular area. A most important entity, this flora has many functions, 
including the provision of a barrier to infection in the individual. 
Normally the organisms that comprise the commensal flora do not cause 
infection in the host. There are exceptions to the rule.  
There are three common features in endogenous infections: 
 a) The infections are produced some distance away from the 
normal habitat of the organisms. 
 b) Such infections are frequently a manifestation of lowered tissue 
resistance or tissue damage. 
 c) Problems of endogenous infections are generally confined to 
patients, in that they do not generally constitute high cross-
infection risks (Ross, 1979). 
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1. 1.5.2 Exogenous Infections: 
Exogenous infections represent the greater proportion of infections 
and are derived from man, animals or soil. Man is the most common 
source of exogenous infections, either when the patient is suffering from 
clinical infection or when the person is a carrier of infection (Ross. 1979). 
1.1. 6   Surveillance of Infections: 
Surveillance is the key note of infection-control programs. The 
descriptive epidemiologic data collected by surveillance methods are 
essential for rational control efforts. Such surveillance data are. 
 a) Provide baseline rates for detecting increased frequency of 
infection (outbreaks or clusters).  
b)    Measure the use and effectiveness of known methods of 
control.  
c)  Delineate host procedure and other factors responsible for 
endemic levels.  
d)    Provide a basis for evaluating the effect of changes in 
techniques or equipment. 
Potential sources of surveillance data include the hospital record 
room, the microbiology laboratory; the pharmacy (for review of antibiotic 
usage) and the wards. 
Infections may be tabulated by infection site, agent, ward and 
service (Clark and Malnan, 1981). 
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1. 1.7 Transmissibility of Infection: 
There are several factors involved in the transmission of infection 
from the original to the new host. The size of infecting dose is important 
because successful transmission depends on having sufficient number of 
organisms present to enter the body, overcome the host resistance and 
become established in the tissues. 
Infections may be classified based on, transmissibility into: 
1.1. 7. 1. Localized Infections: 
Many infections remain localized and only become generalized:  
a) If the organism becomes more virulent.  
 b) If the host resistance is decreased. 
 c) If the bacteria gain access to another susceptible part of the     body. 
1.1.7.2 Generalized Infections: 
Some organisms are highly invasive when they enter the body and 
produce a generalized infection, some are acute and others are sub acute. 
Spread can be direct by cerebrospinal fluid (CSF), by the blood or by the 
lymphatic system (Ross, 1979). 
1.1.8 Factors That Predispose to Infection:  
1. 1. 8.1 Host Factors:  
   Host-related factors which are likely to predispose to 
infection include: 
23 
 
   a) Age susceptibility to infection is greatest in the very young and 
elderly. It probably relates to the effectiveness of inflammatory 
and immune Responses.                                                                                           
    b) Genetic factors. 
    c) The sex of the host. 
   d) Pre-existing disease.  
1.1.8. 2   Environmental Factors:  
The most important environmental factors which may predispose to 
infection include nutrition, climate and animal contact.  
1. 1.8. 3 Local Factors: 
Some areas of the body have very poor resistance to infections, 
e.g.; anterior chamber of the eye and joints.  
1. 1. 8.4 Other Factors:  
       These include surgical interference, poor blood supply and presence 
of foreign bodies (Elegail, 1994).  
1.1.9 Types of Infection: 
Infections associated with any hospitalization can be divided into 
two categories (Rayan, 1984): 
1. 1. 9.1 Community-acquired Infections: 
As defined by the centre for Disease Control (CDC) community-
acquired infections are those infections that are present or incubating at 
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the time of hospital admission, and may be important as they are 
potentials for spread within the hospitals. 
All others are considered nosocomial infections, including those 
that appear within 14 days of hospital discharge (Ryan, 1984). 
1. 1. 9.2 Nosocomial Infections: 
A nosocomial infection is an infection that is not present or 
incubating when a patient is admitted to a hospital. Bacterial nosocomial 
infections generally have onset' more than 48 to 72 hours after hospital 
admission, or a nosocomial infection is one acquired during 
hospitalization (Lennette et al., 1985). Moreover, an infection classified 
as nosocomial is one in which the patient first becomes symptomatic 
more than 48 hours after admission, and the incubation period was  
shorter than the duration of hospitalization or was known (Clark and 
Malnan, 1981)  
In determining whether a given infection is nosocomial or 
community- acquired, the incubation period of the specified infection, 
e.g. varicella or hepatitis-B, must be considered. Some nosocomial 
infections, e.g. surgical wound infections, may have onset after a patient 
is discharged from the hospital. Such infections are less likely to be 
recognized by infection control. Personnel infection onset during with 
than hospitalization (Lennette et al., 1985).  
Nosocomial infections may be either endogenous or exogenous (Maki, 
1978) endogenous infections are caused by those organisms that are 
present as part of the normal flora of the patient. Exogenous infections are 
those caused by organisms acquired by exposure to hospital personnel, or 
the hospital medical device, environment (Lennette et al., 1985). 
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Examples of nosocomial infections include:  
  a) Urinary tract   infections in most hospitals between one third 
and one-half of all nosocomial infections are of the urinary 
tract and urinary tract infections are the most frequent cause of 
Gram-negative sepsis.  
b) Respiratory infections: pneumonia is the nosocomial 
infection most often recognized as contributing to death.  
c)   Postoperative infections: postoperative infections constitute 
one-third of all nosocomial infections in most institutions. 
Most wound infections probably come from patient or 
personnel through direct contact during the' operation or 
later in recovery rooms or wards.        
d) Infections following intravenous therapy:  two to eight 
percent of patients with plastic cannulas in veins over 48 
hours develop bacteraemia and non- superlative phlebitis 
(Clark and Malnan, 1981). 
1. 1.9.3 Incidence of Nosocomial Infections: 
   It has been estimated that approximately 5.5% of hospitalized 
patients develop nosocomial infection (Dixon, 1978). Combining this 
incidence with the number of patients admitted annually to hospitals 
yields an estimate of approximately 2 nosocomial infections occurring 
each year (Bennett, 1978 and Dixon, 1978). 
During a 3-year period from 1972 to 1975, the nosocomial 
infection rate of the University of Virginia Hospital was 6 per 100 
admissions or 6% (Wenzel et al., 1976). Also an annual rate of 
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nosocomial infection in 1980-1982 .ranged from 23.8 to 42.4 per 10,000 
patients discharged (Hughes et al., 1983). 
The National Nosocomial Infections study (NNIS) is a nation-wide 
surveillance system organized by, the Centre of Disease Control (CDC) 
in 1970 in the United States. NNIS represents the only source of current 
national data on the incidence of and trends in the rate of nosocomial 
infections (Hughes et al., 1983). 
The urinary tract is the most common site of nosocomial infections, 
accounting for approximately 41% of all nosocomial infections reported 
by CDC during 1980- 1983. During this period surgical wound infections 
accounted for 19% of infections, lower respiratory tract infections 
accounted for 16%, and primary. Bacteraemia accounted for 6%. 
Infections at all other sites accounted for the remaining 18%, of 
infections. 
Infections rates vary by the type of hospitals (Lennette et al., 1985). 
1. 1.9. 4 Modes of Transmission of Nosocomial Infections: 
Four modes of transmission of nosocomial pathogens exist 
(Branchman, 1979). The most common mode of transmission in U.S. is 
contact transmission, which may result from direct contact between 
patients or between patients and patent-care personnel. Indirect contact 
transmission occurs when inanimate objects in the environment, e.g. 
endoscopes, become contaminated and are not adequately disinfected or 
sterilized between patients. Droplet transmission, another form of contact 
spread, occurs by means of large droplets, which can spread over a few 
feet. 
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The second most common mode of transmission is common 
vehicle transmission. Example of contaminated common vehicles 
implicated in the transmission of nosocomial infections includes food, 
blood and blood products, diagnostic reagents and medications. 
The third most common mode of transmission is airborne 
transmission. In such instances, infectious agents have been transmitted 
over great distances. Vector-borne transmission of nosocomial pathogens 
is rare (Lennette et at., 1985). 
1.2. Wound infection 
1.2.1. Definition 
Wound occurs when break in the continuity of skin or mucus 
membranes expose the underlying tissue; this may result from accidental 
injuries, burns, surgical operation and in case of puerperal uterus 
infection .   (vilar,2000). 
 Infection is mechanism through which microbial agents reach their 
Potential victims and elicit pathogenic reaction (vilar,2000). 
1.2.2. Classification of Wound: 
1 .2.2.1.  According to Source of Infection in to: 
a) Endogenous infection: 
Are caused by organisms that have been leading commensal existence 
elsewhere in Patient's body for example, an abdominal Surgical wound 
may become inflicted with organisms from the large bowel after an 
operation involving incision of colon  
b) Exogenous infection: 
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The source of infecting organism is out with body of Patient who 
Becomes infected cross infection is a particular example of exogenous 
infection in which the causal organism is spread from person to another 
.Infection may occur after accidental or Intentional trauma of the skin or 
other tissue .The latter type is often called “Surgical or post operative 
sepsis, (Mackie and McCartney, 1996). 
 
1.2.2.2 According to site of infection: 
(a) Soft tissue infection: soft tissues are generally associated with the 
production of Pus and the bacteria involved are said to be pyogenic (Pus 
–Producing). Not all infection of skin and subcutaneous tissue are 
supportive in the sense described above (Mackie and McCartney, 1996). 
(b) Bone infections: Osteomyelitis and osteitis secondary to a contiguous 
infections commonly Polymicrobial with aerobic and anaerobic 
components 
 (Mackie and McCartney, 1996).  
1.2.2.3 According to Surgical Operation:  
(a) Clear operation wound: clear surgery that does not involve incision 
through the gastro intestinal, respiratory, or genitourinary tract the most 
common causative organism is Staphylococcus aureus (vilar,2000).  
(b) Contaminated operation wound: Surgery that involves a site with 
known normal flora apart from the skin, which presents additional risk of 
contamination of wound. This includes the colon, gall-bladder, mouth and 
vagina. The causative organisms are gram-negative bacilli and anaerobes 
such as bactericide fragilis. Dirty (infected) operation wound: The 
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operation site may occasionally be infected at the time of surgery, as with 
the incision of an abscess (vilar,2000). 
1.2.3 Causitive Agents of Wound Infections:  
       The type of organism depends on the site and nature of the surgery or 
trauma. Wound infection following colon, rectal surgery often contains 
bacteria from large bowel (E.coli, Bacteroids spp, etc). Wound infection 
following bites will contain mouth organisms from the biting animal 
wound infection are often caused by organism resident on the skin surface 
which has been breached. The main culprit here is Staphylococcus aureus 
and this is the only constituent of normal skin flora that is worth looking 
for routinely common: S.aureus, B.haemolytic, Streptococci, E.coli, 
Clostridium perfringens, anaerobic cocci (Manian and Meyer, 1990).  
The causative agents of wound infections are Staphylococci (30-50%) of 
all wound infective, Klebsiella species, Pseudomonas aeruginosa, E. coli, 
Proteus species, Bacteroides species, Clostridium perfringens, 
Enterococci, anaerobic Streptococci, anaerobic Staphylococci . Wound 
infections can be caused by Vibrio vulnifcus which is halophilic marine 
vibrio that produced infection in wound exposed to sea -water or raw 
shell-fish (Elegail,1994). Enteric Gram - negative rod 
(Enterobacteriaceae) are large hetrogenous group of Gram negative Rod, 
facultative anaerobes or aerobes, ferment a wide range of carbohydrates, 
Possess a complex antigenic structure, and Produce a variety of toxins 
and others virulence factors, these bacteria may also called coli forms ( 
Brooks et al ; 2001 )  
The natural habitat is the intestinal tract of humans and animals (Brooks 
et al; 2001). 
1.3 Classification of Entrobacteriaceae: 
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1.3.1 Classification of Entrobacteriaceae: 
The Taxonomy of Enterobacteriaceae is complex and rapidly 
changing since the Introduction of techniques that measure evolutionary 
distance, such as nucleic acid Hyperidization and sequencing. More than 
25 genera and 110 species or groups have been defined; however, the 
clinically significant Enterobacteriaceae comprise 20-25 species, and 
other species are encountered infrequently. The family includes many 
genera (Escherichia, Shigella, Salmonella enterobacter, Serratia, Proteus 
and others. (Brooks et al; 2001). 
1.3.2 Characteristics: 
They are gram-negative rods, either motile with Peritrichous 
flagella or non motile; they grow on peptone or meat extract media with 
out the addition of sodium chloride or others supplements; grow well on 
MacConkey agar, grow aerobically and anacrobically (are facultative 
anaerobes ). Ferment rather than oxidize glucose, often with gas 
Production; are catalase Positive, oxidase negative, and reduce nitrate to 
nitrite. 
1.3.3 Example of important Pathogens: 
1.3.3.1. Escherichia coli: 
       A normal inhabitant in human and animal intestine, grows well as 
large colonies after overnight incubation. Most strains are motile, some 
strains are capsulate. Usually, ferments lactose, Indole producer. (Sleigh; 
1994). 
 E. coli is an important cause of sepsis: 
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a) Urinary tract infection, wound infection especially after surgery of the 
lower Intestinal Tract, Peritonitis, Biliary Tract infection septicaemia, 
neonatal meningitis. (Sleigh 1994). 
b) Diarrhoea despite being a normal gut commensally, E-coli is a 
common cause of diarrhoea infantile gastroenteritis, tourist diarrhoea and 
hemorrhagic diarrhoea. 
 
1.3.3.2 Klebsiella pneumoniae: 
       Normal habitat in human and animal intestine. Some strains are 
saprophytes in Soil, water and vegetation. They Survive well in moist 
environments in hospital (Sleigh 1994). 
Always large and mucoid (due to possession of a prominent 
capsule) on blood agar, CLED agar and MacConkey agar (Sleigh 1994) 
Klebsiella causes urinary tract infection, septicaemia , meningitis 
(especially in neonates).Rarely abscess, endocarditic and other lesions 
.some time associated with chronic nasal and or pharyngeal sepsis and 
Pneumonia (Sleigh 1994) . 
1.3.3.3 Proteus vulgaris: 
         Normal habitat in human and animal intestine .Some strains are 
saprophytes and are found in soil and water. (Sleigh 1994). 
Grow well on routine media. A swarming type of which may cover the 
whole plate is produced on ordinary media by Proteus mirabilis and 
Proteus vulgaris. Proteus forms colourless colonies on MacConkey‘s 
agar and blue green colonies on CLED agar. (Sleigh 1994). 
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       Proteus mirabilis is main Proteus species of medical important. It is 
a common cause of urinary infection in elderly and young males and 
often following catheterization or cystoscopy. Infections are also 
associated with the presence of renal stones. 
     Abdominal and wound infections, Proteus is often secondary invader 
of ulcer, pressure sores, burns and damaged tissues. Septicaemia and 
occasionally meningitis and chest infections. Proteus vulgaris is 
occasionally isolated from urine, pus and others specimens. Proteus 
mirabilis infections usually respond better to antimicrobial therapy than 
those caused by Proteus vulgaris (Cheesbrough; 2000). 
1.3.3.4 Pseudomonas aeruginosa: 
Is a Gram-negative bacillus, non sporing, non-capsulate, and 
usually motile by virtue of one or two polar flagella. It is strict aerobe but 
can grow anacrobically if nitrate is available. (Green wood et al., 2002). 
Most saprophytes are found widely in soil, water and others moist 
environments (Green wood et al., 2002). 
The organism grows readily on a wide variety of culture media 
over a wide temperature range and emits a sweet grape-like odour that is 
easily recognized. (Green wood et al., 2002). 
Most strains produce diffusible pigment, typically the colony and 
surrounding is greenish-blue. The most common colonial form is relative 
large, low convex with an irregular surface, energy from carbohydrate by 
an oxidative rather than a fermentative metabolism. All strains give a 
rapid positive oxidase reaction within 30 seconds (Green wood et al., 
2002). 
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         Pseudomonas aeruginosa can infect almost any external sites or 
organ most community infections are mild and super-facial, but in 
hospital infections are more commons more sever and more varied 
(Green wood et al., 2002). 
1.3.3.5 Staphylococcus aureus: 
Staphylococcus aureus is the commonest pathogen isolates from 
subcutaneous abscesses, and skin wounds (Cross infection) common 
causes of hospital acquired wound infection and ulcer, ostomyelitis and 
septicaemia. 
Staphylococcus aureus is carried in the nose of 40% or more of 
healthy people (Cheesbrough, 2000).  
1.4. Antibiotics 
Drugs active against microorganisms are classified in to synthetics and 
antibiotics (Fadlalla ,2005) 
1.4.1. Definition: 
       Antibiotics are substances produced by microorganisms that inhibit 
the growth of or kill other, microorganisms. Most antibiotics are 
secondary metabolites, which are produced at the end of growth phase of 
microorganisms.Antibiotics have selective toxicity, which enables drugs 
selectively to kill microorganisms or inhibit its growth while leaving the 
host, relatively unharmed. (Fadlalla,2005). 
1.4.2. Effect: 
Antibiotics exert an effect in the patient that is either bactericidal or 
bacteriostatic. Those antibiotics that are bacteriostatic, e.g. 
chloramphenicol، erythromycin، tetracycline, inhibit bacterial cell 
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replication but do not kill the organisms. Other anti biotics, e.g. 
.penicillins, cephalosporins, aminoglycosides, are bactericidal; they cause 
microbial cell death, or lysis. A few compounds, e.g. sulfonamides, are 
either cidal or static according to the composition of the environment 
(blood, pus, urine, etc) in which the infecting organisms are growing 
(Pratt, 1977). 
1.4.3. Antibiotics Sources: 
     Most antibiotics are produced by actinomycetes and others 
produced by fungi and true bacteria. 
1.4.4. Antibiotics action:  
Antibiotics act in one of two ways either microbiostatically when 
they inhibit the growth of pathogens and are called bacteriostatic when 
they act on bacteria e.g. chloramphenicol and tetracyclines or 
microbicidally when they kill the pathogens and are called bactericidal 
when act on bacteria e.g.penicillins, cephalosporins, aminoglycosides and 
sulphonamides. 
14.5. Cephalosporins:  
       The naturally occurring cephalosporins "cephlosporin  were first 
isolated from Cephalosporium fungi in 1945 (Robert and Bryan, 1991). 
 It is a B-lactam compound with a nucleus 7-aminocephalosporanic 
acid (Brooks, et al.,1995) which consist of B-lactam rings fused to 
dihydrothiazin ring various substitution at the 3 and 7 position alter their 
antibacterial activity and pharmacokinetic properties (Albert et al.,1991 ) 
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1.4.5.1. Mode of Action:  
        Cephalosporins are bactericidal similar to penicillin. They act by 
inhibiting synthesis of the bacterial cell wall by binding a bacterial 
enzyme that is necessary for the formation of celI wall (Eldawa, 1992). 
      The mechanism of action of cephalosporins is analogous to that of 
penicillin, binding to specific Penicillin Binding Proteins that serve as 
drug receptor on bacteria, inhibiting cell wall synthesis by blocking the 
transpeptidation of peptidoglycan and activating autolysis enzymes in the 
cell wall that can produce lesions resulting in bacterial death (Brooks et 
al., 1995 ) . 
 
1.4.5.2. Pharmacokinetics 
        Many cephalosporins require parenteral adminisation but a few are 
available in oral form. Relatively high concentration of these agents are 
attained across the placenta and in synovial, pleural, and pericardial, bile 
levels are usually high, especially with cefoperazone which excreted in 
bile (Albert, et al., 1991). 
       Cephalosporins are usually excreted in urine unchanged but some 
form a desacetyl metabolite (Eldawa, 1992). All cephalosporins are 
excreted primarily by the kidney, except cefoperazone (Albert, et at., 
1991). 
1.4.5.3. Adverse effects: 
        Cephalosporins are generally very well tolerated. The most common 
side effects are diarrhoea and hypersensitivity reaction such as rash, drug 
fever and serum sickness. Other infrequent effects include pseudo 
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membranous colitis, elevated serum creatinine and transaminase levels 
and leucopoenia thrombocytopenia and coombs positive haemolytic 
anaemia. These abnormalities are usually mild and reversible (Albert, et 
aI., 1991). 
1.4.5.4. Classification: 
      The most widely used system of classification of cephalosporins is by 
generation.   It is based on the general features of their antibacterial 
activity and pharmacokinetics characteristic but may depend to some 
extent on when they were introduced (Eldawa, 1992). 
 
 
1.4.5.4.1. First Generation:  
      The first generation are very active against Gram-positive cocci 
except Enterococci and methicillin resistant Staphylococcus aureus, and 
moderately active against some Gram negative rods, primarily 
Escherichia coli, Proteus spp and Klebsiella spp Anaerobic cocci are 
often sensitive. Bacteriods-fragilis is resistant (Brooks, et al, 1995). Have 
moderate activity against Haemophilus influenzae. 
         First generation Cephalosporins include Cefadroxil, 
Cefazolin.Cephalexin, Cephaloridine, Cephalothin, Cephapirin, and 
Cephradine (Albert, et al., 1991). 
Cephalexin, Cephradine, and Cefadroxil are absorbed from the gut to a 
variable extent and can be used to treat urinary and respiratory tract 
infections. Other first generation cephalosporins must be injected to give 
adequate level in blood and tissues; Cefazolin is a choice for surgical 
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prophylaxis because it gives highest 90-120 mg/ml levels. Cephalothin 
and cephapirin in the same dose give lower level, none of them penetrate 
the central nervous system and they. Are not drug of choice for any 
infection (Brooks et al., 1995). 
1.4.5.4.2. Second Generation: 
        The second generation cephalosporins are heterogeneous group, all 
are active against organism covered by first generation drugs, but have 
extended coverage against Gram- negative rods including Klebsiella spp, 
Enterobacter spp and Proteus spp but not pseudomonas aeruginosa  
(Brooks et al., 1995). 
         Oral second generation cephalosporins can be used to treat sinusitis 
and otitis media caused by Haemophilus infuenzae including B-Iactamase 
producing strains (Brooks et al., 1995). 
      Cefoxitin and Cefotetan are particularly active against Bacteriodes 
fragilis and thus are used in mixed anaerobic infections including 
peritonitis or pelvic inflammation. Cefamandale, Cefuroxime, Cefonicid 
and Ceforanide are injected intravenously at internal in the treatment of 
Gram-negative bacterial pneumonias or other community acquired 
infections (Brooks et al., 1995). 
 1.4.5.4.3. Third Generation 
       Third generation Cephalosporins have little activity against Gram- 
positive cocci, Staphylococci and Enterococci. Often produce super 
infection during their use. A major advantage of third generation drugs is 
their enhanced activity against Gram-negative rods. Where as second 
generation drugs tend to fail against Pseudomonas aeruginosa, 
Ceftazidime or Cefoperazone may succeed. Thus third generation drugs 
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are very useful in the management of hospital acquired Gram-negative 
bacteraemia. In immunocompromised patients, these drugs are often 
combined with aminoglycosides; Ceftazidime may also be lifesaving in 
severe melioidosis (pseudomonas pseudomallei infection). Another 
important distinguishing feature of several third generations except 
Cefoperazone is the ability to reach central nervous system and to appear 
in the spinal fluid in sufficient concentration to treat meningitis caused by 
Gram-negative rod. Cefotaxime, Ceftriaxone, Ceftazidime are given 
intravenously and considered the choice for management of gram 
negative bacterial sepsis and meningitis (Brooks et al., 1995). 
     Third generation Cephalosporins broad spectra of Gram-negative 
activity is due to their stability to B-lactamase and their ability to 
penetrate through the outer cell envelope of Gram-negative bacilli, there 
are two sub groups among these agents: those with potent activity against 
pseudomonas aeruginosa (Ceftazidime and Cefoperazone) and those 
without such activity (Ceftizoxime, Cefotaxime, Ceftriaxone and 
Moxalactam (Awad, 2007). 
Cefotaxime inhibits more than 90% of strains of Enterobacteriaceae. It 
has moderate activity against anaerobes. Ceftazidime, Ceftriaxone and 
moxalactam have spectra activity similar to that of Cefotaxime with few 
exceptions. Ceftriaxone is the most active agent against penicillinase 
positive or negative strain of Nesseria gonorrhea (Albert, et aI., 1991). 
Moxalacam 
an oxa B-lactam, is less active against Gram- positive cocci including 
Staphylococci and Streptococci. It has slightly more activity 
against Pseudomonas species than Cefotaxime. It is the most active third 
generation agent against anaerobes including Bacteroides -fragilis. 
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        Cefoperazone is less active than Cefotaxime against many 
Enterobacteriaceae and Gram-positive cocci. However it has activity 
against Pseudomonas aeruginosa, it is activity against anaerobes is 
similar to that of Cefotaxime . (Lesch,et al ;2001) 
       Ceftazidime is the most potent of the currently available 
Cephalosporins against Pseudomonas aeruginosa. It is more active than 
ureidopenicillins against these strains. This agent has activity similar to 
that of cefotaxime against the Enterobacteriaceae but is not as active 
against Gram-positive cocci it has little activity against Gram negative 
anaerobes. Cefixime, the first oral third generation Cephalosporins, has 
activity against Gram-negative aerobes similar to that of Ceftazidime. It is 
more stable than other oral Cephalosporins against Gram-negative 
bacteria. Compared with these agents Cefixime is equally active against 
streptococci but considerably less active against Staph aureus. None of 
the currently available cephalosporins is active against Enterococci 
(Albert, et aI, 1991) 
1.4.5.4.4. Fourth Generation 
          New Cephalosporin's are being classified as fourth generation 
drugs. The new agents have comparable or slightly enhanced activity 
against Enterobacteriaceae that are resistant to third generation. They are 
not active against Pseudomonas aeruginosa that are resistant to the third 
generation. The activity against Streptococci and Naficillin susceptible 
Staphylococci is comparable to the third generation compound. Example 
of fourth generation is Cefepime (Brooks, et al., 1995). 
1. 5. Microbial Resistance: 
The wide spread use of antibiotics lead to the occurrence of drug 
resistance among microorganisms. The resistances have occurred due to a 
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change in the nature of genes. (David, 1980). A change in the genome of 
a bacterial cell may be caused either by a mutation in the chromosome of 
the cell or result from the acquisition of additional DNA from an external 
source. DNA may be transferred between bacteria by three mechanisms: 
transformation, transduction and conjugation... (Green wood et al., 2002). 
a-   Transformation:  
      Genetic Transformation occurs by transfer of naked DNA from donor 
to recipients through the medium. (David, 1980). Most species of bacteria 
are unable to take up exogenous DNA from the environment. Indeed most 
bacteria produce nuc1eases that recognize and break down foreign DNA. 
However, bacteria in some genera, notably pneumococci, Haemophilus 
influenzae and certain Bacillus species have been shown to be capable of 
taking up DNA either extracted artificially or released by lysis from cells 
of another strain. Cells are competent for transformation only under 
certain conditions of growth usually in late log phase or during 
sporulation (Green wood et al., 2002). Transformation is limited to Gram 
positive bacteria but an exception is Haemophilus. (Fadlalla, 2005).  
b-   Transduction:   
          Transduction is the process that involves the transfer of small 
amount of DNA, which is carried, from donor to recipients by specific a 
bacteriophage. It occurs in both Gram negative and Gram positive 
bacteria. For example Penicillin resistance in Penicillinase-producing 
Staphylococcus is a result of transduction. In spite of the presence of 
antibiotics resistance due to transduction, it is not responsible for multiple 
drug resistance. (Fadlalla, 2005).  
c-   Conjugation:  
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           Conjugation is the process in which one cell, the donor or male cell 
makes contact with another, the recipient or female cell and the DNA is 
transferred directly from the donor into the recipient. Certain types of 
plasmids carry the genetic information necessary for conjugation to 
occur. Only cells that contain such a plasmid can act as donors, those 
lacking a corresponding plasmid act as recipients... (Green wood et al., 
2002 ).Although transfer seems to be confined to gram negative bacteria 
,the process allows the passage of any number of genes so that 
conjugation is responsible for multiple drug resistance .It is now known 
that the conjugation process is responsible for transfer of extra 
chromosomal genetic elements called resistance-factors (R- factors). 
(Fadlalla, 2005).  
1.5.1 The Genetic Basis of Antibiotic Resistance:  
      Genes determine all the properties of microorganisms located either 
on the chromosome or on plasmids or on lysogenic bacteriophages. With 
regard to antibiotic resistance it is important to distinguish between 
intrinsic and acquired resistance... (Green wood et aI, 2002)  
a - Intrinsic Resistance:  
        Intrinsic resistance is dependent upon the natural insusceptibility of 
organisms to a particular drug and will always exist. Intrinsic resistance is 
usually predictable in a clinical situation and should not pose problems 
provided that an informed and judicious choice is made of appropriate 
antimicrobial therapy.  
b - Acquired Resistance:  
       A problem of chemotherapy has been the appearance of resistance to 
particular drugs in a normally sensitive microbial population. An 
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organism may lose its sensitivity to an antibiotic during a course of 
treatment. Once resistance has appeared, the continuing presence of an 
antibiotic exerts a selective pressure in favour of the resistant organisms. 
Three main factors affect the frequency of acquired resistance, the first is 
the amount of antibiotic which is being used, the second is the frequency 
with which bacteria can undergo spontaneous mutations to become 
resistant and the last one is the prevalence of plasmids able to , transfer 
resistance from one bacterium to another. 
1.5.2 Control of Antibiotic Resistance:  
        The major cause of the spread of genes conferring antibiotic 
resistance is the selection pressure brought about by the increasing use of 
antibiotics in animal and humans, because antibiotics are used as animal 
feed supplements and used for treatment of animal populations and 
human patients. So it is important to minimize the use of antibiotic as 
much as possible and to reduce the chance of cross- infection. Restriction 
use and availability of antibiotics could prevent further spread of R 
plasmid and may reduce their incidence. (Green wood et al., 2002). 
1.6. Objectives: 
1.6.1 General objective: 
     The aim of this research is to evaluate the activity of the 
cephalosporins against organisms isolated from wounds infection. 
1.6.2 Specific objective  
a - To isolate and identify the organisms from infected wounds. 
b- To measure the susceptibility and resistance of the causative agent 
to different antimicrobial agents. 
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Chapter Two 
2-Materials and Methods 
2.1 Study area: 
This study was done on specimens collected from Khartoum 
Teaching Hospital, AL Amal National Hospital and National Health 
Laboratory during January 2005 – to September 2007. 
2.2 Sample size: 
Two hundred clinical specimens were collected randomly from 
males and females, from infected wounds. 
2.3 Age Group:- 
The patients were divided into 5 age groups as follows. 
 
1  — 15 
16 — 30 
31 — 45 
46 — 60 
       > 60 
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2 .4 Materials: 
2.4.1  Biological Materials:  
Blood Veterinary Research Labs Center` (soba) 
Plasma Veterinary Research Labs Center (soba) 
2.4.2 Chemicals and Reagents: 
Absolute Ethanol The British Drug Houses Ltd 
Amyl alcohol The British Drug Houses Ltd 
Crystal Violet The British Drug Houses Ltd 
Glucose  Oxoid Ltd., England  
Hydrochloric Acid  The British Drug Houses Ltd. 
Hydrogen Peroxide The British Drug Houses Ltd. 
Immersion Oil The British Drug Houses Ltd 
Legal’s Iodine solution  The British Drug Houses Ltd 
Methyl red indicator The British Drug Houses Ltd 
P-Dimethyle-  
Aminobenzoic- Aldehyde The British Drug Houses Ltd 
Safranin Red The British Drug Houses Ltd . 
Savlon Imperial Chemical Industries Ltd. 
Sodium Chloride Oxoid Ltd. England 
Sodium Hydroxide  The British Drug Houses Ltd. 
Tetramethyl-p-phenylene-diamine . 
dihydrochloride (oxidase reagent) The British Drug Houses Ltd 
'Urea  . Abbott Ltd. U.K. 
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 2.4.3  Culture Media  
Bacteriological Peptone Oxoid Ltd . ، England  
Blood Agar base Oxoid Ltd., England 
Eosin Methylene Blue agar  Oxoid Ltd., England  
Kligler Iron Agar Oxoid Ltd . ، England  
MacConkey Agar Himedia . ، India  
Mueller & Hinton Medium Oxoid Ltd.,.England 
Nutrient Agar  xoid Ltd., England  
 Nutrient Broth Oxoid Ltd., England 
Peptone Water  Oxoid Ltd., England  
Simmon's Citrate Medium Plasmatec Labs. U.K . 
Urea Agar Base Plasmatec Labs. U.K. 
 
2.4.4  Equipment and Instruments: 
Autoclave Baird & Tatlock, England 
Balance Adam Equipment Co. England 
Colony Counter Gallenkam P. England 
Glass Ware etc…. Griffin & George Ltd. England 
 and Kimax ltd . U.S.A' 
Hot Air Oven Memmert,Germany. 
Incubator Baird & Tatlock, England. 
Microscope  Olympus, type CH20, Japan. 
Microscope slide Horwell Limited, London, UK. 
Imm thick  
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Swabs Medical Disposable Industrial 
 Complex (MDIC).Saudi Arabia 
Water Bath Grant Ltd, England. 
Wire Loop Holder Baird & Tatlock, England. 
  
 
2.5 Experimental work 
2.5.1 Collection of Specimens  
   The specimens were collected from infected wound by using sterile 
cotton wool swab for wound. 
2.5.2 Inoculation  
    Under aseptic conditions near Bunsen burner, the specimens were 
inoculated on blood agar and MacConkey‘s agar. 
2.5.3 Incubation  
     The inoculated plates were transferred to the incubator and incubated 
aerobically at 37°C    for 24 hours. 
2.5.4 Examination of Growth  
      The primary culture on MacConkey‘s and blood agar that showed 
significant growth was examined for fermentation on MacConkey‘s agar 
and haemolysis on blood agar. The morphological character, size, shape, 
colour, pigment production, haemolysis, odours were studied. 
      The resultant growth was subcultured on nutrient agar and stored for 
further investigation. 
2.5.5 Identification  
The following techniques were used to identify the isolates: 
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2.5.5.1 Gram Stain 
     This was use to differentiate the bacteria into Gram- positive and 
Gram-negative. During examination of smears bacterial shapes and 
arrangements were studied, the technique was done as follows: 
a- A portion of colony was emulsified in a drop of normal saline in 
clean slides and then spread evenly to prepare thin smear. 
b- The smear was fixed by gentle heat and covered with crystal 
violet for one minute, then washed rapidly with clean water. 
c- Lugol iodine was added for one minute and washed with clean 
water. 
d- Alcohol was added for few seconds and washed rapidly by clean 
water. 
e- The smear was covered with safranine (counter stain) for two 
minutes and then washed with clean water. 
f- The smear was examined microscopically, after air drying, using 
oil immersion lens. The results were reported. 
2.6 Methods: 
2.6.1 Isolation of clinical isolates: 
         The swab was inoculated on sterile blood agar plate and 
MacConkey agar plat and then streaked by means of a wire loop. 
The plates were incubated aerobically at 37°C overnight. On 
MacConkey agar plat, the lactose and non- lactose fermenting 
colonies were isolated. Subcultures were made on MacConkey's 
agar and nutrient agar. On blood agar plate the B-haemolytic and 
alpha- haemolytic and non- haemolytic colonies were isolated. 
Subcultures were made on blood agar, mannitol salt agar and 
nutrient agar. 
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              In this study, different types of culture media were used 
to differentiate many types of bacteria. 
(a) MacConkey's agar : 
It is a differential/selective medium used for cultivation of Entero 
bacteria and for differentiation lactose fermenting of non-lactose 
fermenting Entero bacteria. 
(b) Nutrient agar : 
It is a basic ordinary culinary culture medium used for culturing 
bacteria at 37°C for 24 hours. All samples were cultured and 
incubated under aerobic conditions. 
(c) Blood agar: 
It is used to differentiate organisms that may be Beta haemolytic 
or Alpha haemolytic or non-haemolytic one. 
(d) Mannitol salt agar: 
           It is a selective medium used for isolation of Staphylococci 
(e) Eosin Methylene Blue agar: 
          It is a selective media used in identification of E.coli. 
2.6.2 Purification of the Isolated Colonies 
         This was done by streaking the organisms on Nutrient agar. Single 
colonies of purified cultures were further sub cultured on sloping agar 
incubated aerobically at 37 ºC for 24 hours and then preserved in 
refrigerator at 4ºC  until they were used. 
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2.6.3 Microscopical Examination of the Clinical Isolates: 
     All these isolates were subjected to microscopical examination to 
study their morphology and staining properties using the Gram's staining 
technique Which involved the following steps; fixation of the isolates 
then covering with crystal violet (60 sec) and washing with water then 
covering with iodine (60 sec) and washing then colorization with alcohol 
and washing then covering with safranin (30- 0 sec) and washing then 
leaving the slide to dry to be ready for examination by microscope. 
2.6.4 Biochemical Tests Adopted for Identification of 
Bacterial Isolates:  
I. Catalase Test:  
         This test acts as a catalyst in breakdown of hydrogen peroxide to 
oxygen and water and is carried out by pouring 2-3 ml hydrogen peroxide 
in test tube, and using sterile wooden stick or glass rod to remove several 
colonies which were grown on blood free media then immerse in 
hydrogen peroxide solution. Bubbles of oxygen are released if the 
organism is catalase producer. It is used to differentiate bacteria that 
produce a catalase enzyme such as Staphylococci from non- catalase 
producer e.g. Streptococci. (Cheesbrough, 2000). 
II. Citrate Utilization Test:  
          This test is based on the ability of an organism to use citrate as the 
only source of carbon and ammonia as the only source of nitrogen. The 
test organism was inoculated in a medium, which contains sodium citrate, 
ammonium salt and the Bromothymol blue as indicator or (Simmons 
citrate medium which is a modification of Kosers medium with agar and 
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an indicator) then incubated at 37c  for up to four days. Citrate Utilization 
appeared by a change in colour of indicator from light green to blue due 
to alkaline reaction.  
III. Coagulase Test:  
        Coagulase causes clot of plasma by converting fibrinogen to fibrin. 
It is carried out by pouring 0.2 m1 of plasma in test tube then adding 0.8 
m1 of test broth culture and incubating at 37c then examining for clot 
after 1 hour, 3 hours and over night. It is used to identify Staph. aureus, 
which is coagulase enzyme producer. (Cheesbrough, 2000). 
 IV. Deoxyribonuciease (DNAse) Test:  
        The test is used to demonstrate the DNase producing organisms 
and is carried out by culturing an organism in a medium containing DNA 
and incubating at 37c over night .The colonies are tested for DNAse 
production by flooding the plate with a weak hydrochloric acid solution, 
the acid precipitates unhydrolized DNA therefore clear zone surround 
DNase producing colonies. It is used to differentiate Staph. aureus from 
other Staphylococci. (Cheesbrough, 2000).  
V.  Indole Test:  
       This test demonstrates the ability of certain bacteria such as E.coli 
to break down   the amino acid tryptophane with the releasing of indole, 
which accumulates in the medium. The test organism was cultured on a 
suitable tryptophane rich medium, mainly peptone water for 48 hours, 
then 0.5m1 of Kovac's reagent is added, a ring of red colour in the alcohol 
layer indicates a positive reaction. (Cheesbroug, 1984). 
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VI. Kligler- Iron Agar:  
        It is a differential slope medium, fermentation of lactose and 
glucose; production of hydrogen sulphide and production of gas are 
reactions used in identification. A yellow butt and red slope indicate the 
fermentation of glucose only. A yellow slope and a yellow butt indicate 
the fermentation of glucose and lactose. A red slope and a red butt 
indicate no fermentation of glucose and of lactose. Cracks and bubbles 
indicate gas production. Blackening indicate hydrogen sulphide 
production. 
VII. Methyl Red Test:  
       The methyl red test is employed to detect the production of 
sufficient acid during the fermentation of glucose by change in the colour 
of methyl red indicator. Inoculate from young aged culture of test 
organism in buffered glucose peptone water, incubate at 37c for 48hour 
then add five drops of methyl red indicator. A positive reaction is 
indicated by a red colour and negative by yellow (Cruickshanck et al., 
1975)  
VIII. Oxidase Test:  
       This test depends on the presence of oxidase enzyme, in certain 
bacteria, that will catalyze the transport of electrons between electron 
donors in the bacteria and a redox dye (tetramethyl-P-phenylene-diamine 
dihydrochloride) (Cruickshanck et al., 1975). A piece of filter paper is 
soaked with a few drops of oxidase reagent (tetramethyl-P-phenylene-
diamine dihydrochloride). A colony of the test organism is then smeared 
on the filter paper. If the organism is oxidase - producer, the phenylene 
diamine in the reagent will be oxidized to a deep purple colour. 
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IX. UreaseTest:  
        This test was carried to assess urease enzyme activity, and it is 
important in recognizing Enterobacteria. The test is carried out by 
inoculating slopes of medium, which contains urea, with test organism 
and incubating at 37C for up to five days and examined daily. If the strain 
is urease producer, the enzymes will breakdown the urea to give ammonia 
and carbon dioxide. The releasing of ammonia makes the medium 
alkaline so the colour of the indicator (Phenol Red) is changed to red-pink 
(Cheesbroug, 1984).  
X. Voges - Proskauer (VP):  
       Many bacteria ferment carbohydrate with the production of acetyl 
methyl carbinol. The test is carried by culturing test organism in glucose 
phosphate peptone water for 48 hours. Sodium hydroxide and small 
amounts of creatinine were added. Under alkaline conditions and 
exposure to the air, a pink colour develops within 2-5 minutes which 
becomes crimson in 30 minutes indicating a positive reaction for acetone 
production. 
2.7 Antimicrobial Susceptibility Testing:    
2.7.1.Antimicrobial Susceptibility Testing:                                                                
The Kirby-Bauer method of antibiotic susceptibility was used in this 
study. 
2.7.1.1. Materials  
2.7.1.1.1. Medium:  Mueller Hinton from Oxoid (U.K.) were used 
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 2.7.1.1.2 McFarland ‘s Turbidity Standard 
 The standard has the turbidity of suspension of approximately 1.5×108   
bacteria/ml. 
Swabs were purchased or local prepared      
2.7.2. Procedure For The Disk Agar Diffusion Method:  
I.  Preparation of Plates:   
        Twenty ml of sterile Mueller and Hinton Sensitivity Agar medium 
was poured into sterile plates. After medium has solidified, the plates 
were dried for 30 minutes in an incubator at 37°C to remove excess 
moisture from the surface.  
II. Preparation of Inoculums and Inoculations:  
        This preparation was done by emulsifying 2 - 3 colonies of the 
test organism in a small amount (about 3 - 5ml) of sterile normal saline or 
nutrient broth. In order to prevent further growth, the diluted and 
standardized inoculums should not be allowed to stand longer than 15 - 
20 minutes before the plates are inoculated. A sterile cotton swab is 
dipped into a suitable diluted culture or suspension and rotated; the swab 
is turned against the side of the bottle to remove excess fluid, and is 
streaked across the medium (David, 1980).  
III. Disk application:  By using a pair of sterile forceps, antimicrobial 
discs ( ceftazidime, cefoperazone, cefotaxime and ceftriaxone) were 
placed into each plate for Gram-positive and Gram-negative. 
IV. Incubation: Within 15 minutes of preparation all plates were 
incubated aerobically at 35º C overnight. 
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V. Reading:  after overnight incubation, diameter of each zone of 
inhibition was measured and recorded to the nearest millimetre. The 
measurements were made with a ruler on the under surface of the plate 
without opening the lid. 
VI. Result: Result of reading was interpreted according to NCCLS Zone 
Diameter Interpretive Standards. 
2.8. Antimicrobial Discs 
The following antimicrobial discs were used in the research: 
a). Ceftazidime (CAZ)         30mg , Abtek Biological Ltd.,UK 
b). Cefoperazone (CFP)        30 mg Oxoid, UK  
c). Ceftotaxime (CTX)        30 mg, Abtek Biological Ltd, UK 
d). Ceftriaxone (CRO)         30 mg Bioanalyse , UK  
2.9. Control Organisms:  
Which include Escherichia coli (ATCC 25922) to control Gram-negative 
bacilli, Staphylococcus aureus (ATCC 25923) to control Gram-positive 
cocci and Pseudomonas aeruginosa (ATCC 27853), the disk placed 
individually with sterile forceps and then gently pressed down on the 
Mueller-Hinton medium without blood or other supplements. In general 
not more than 4 disks were placed on plate; (WHO, 1997). Results of 
reading were interpreted according to the diameters given in the most 
recant NCCLS documents. (National Committee for Clinical Laboratory 
Standards).  
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2.10 Method of data analysis: 
      The data collected was analyzed using statistical package for Social 
Science for Personal Computer (SPSS/PC).  
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Chapter Three 
3- Results 
During the period from January. 2005 – to September. 2007, Two 
hundred wounds swab were collected randomly from Patients 
attending(out-pateints) Khartoum Teaching Hospital, National Health 
laboratory and Alamal National Hospital were Females 70 and Males 
130. 
Bacteriological test showed 173 specimen positive culture " 
significant growth " , 27 no growth from the total positive culture only 
123 gram negative rods according to Biochemical test 50 were Gram -
positive . 
Table 1: Distribution specimens according to sex 
Sex Frequency Percentage 
Males 130 65 % 
Females 70 35 % 
Total 200 100 % 
 
Table 2: Distribution of specimens according to Growth and 
No Growth 
Total Growth No Growth 
 Males Females Males Females 
200 123 50 7 20 
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Table 3: Distribution of the five age groups             
  
Table 4: Distribution of wound Infection according to pathogen 
 
Table 5: Distribution of wound infection according to the age 
Age Group Frequency Percentage 
1 − 15 31 18 % 
16 − 30 40 23 % 
31 − 45 50 29 % 
46 − 60 31 18 % 
> 60 21 12 % 
Total 173 100 % 
 
Age Group Frequency Percentage 
1 − 15  30 15% 
16 − 30 70 35% 
31 − 45 50 25% 
46 − 60 30 15% 
More than 60 20 10% 
Total 200 100% 
Pathogen  Frequency Percentage 
Staph aureus  55 31.8% 
Pseudomonas aeruginosa 45 26 % 
Escherichia coli 28 16.2 % 
Proteus vulgaris 25 14.5% 
Klebsiella pneumoniae 20 11.6 % 
Total 173 100 % 
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3.1 Identification of Staphylococcus aureus: 
3.1.1 Cultural Characteristics: 
 On nutrient agar, golden yellow colonies were observed. On mannitol 
salt agar, it changed the colour of medium from red to yellow. 
3.1.2 Microscopical Examination: 
 With Gram’s staining technique, Gram-positive cocci arranged in 
grape –like clusters. 
3.1.3 Biochemical Reactions :  
Most of the isolates fermented lactose with production of acid and 
didn't form gas. All of them fermented sucrose and mannitol with acid 
production. Most of them fermented glucose with acid production. 
         Almost all of isolates were Catalase-positive, Coagulase-
positive, and DNA se positive. 
The production of coagulase identifies staphylococcus aureus, and 
also DNAse test is a confirmatory test. 
3.2   Identification of Escherichia coli:  
3.2.1 Culture characteristics: 
On MacConkey agar medium, large red colonies were observed as a 
result of lactose fermentation. 
3.2.2 Microscopical Examination: 
With Gram’s staining technique Gram-negative rods were seen. 
3.2.3 Biochemical Reactions: 
All the isolates fermented lactose with production of acid and gas. 
Most of them fermented glucose and sucrose with acid production and 
gas formation. 
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All the isolates give indole -positive result. All of them were Methyl 
red-positive and Voges-Proskauer negative. None of the isolates 
produced urease, utilized citrate or give positive Oxidase. 
All isolates did not change the yellow colour of K.I A both in slope 
and butt, with the absence of H2S production, but all isolates produced 
gas. 
3.3   Identification of pseudomonas aeruginosa: 
3.3.1 Cultural Characteristics: 
On MacConkey‘s agar .discrete pale colonies were observed. On 
nutrient agar most of the isolates produced blue -green pigment which 
diffused in surrounding medium. 
3.3.2 Microscopical Examination: 
With Gram’s staining technique, Gram-negative rods were seen. 
3.3.3 Biochemical Reactions: 
Regarding K.I A, all of them changed the slope colour to red, and 
most change the butt to red with out H2S or gas production. 
Pseudomonas aeruginosa is non-lactose fermenting .All isolates 
fermented glucose and none of them fermented sucrose. All isolates 
were Oxidase-positive, indole-negative، Methyl red and Voges –
Proskauer  negative. 
 
3.4   Identification of Klebsiella pneumoniae : 
3.4.1 Cultural characteristics:  
On MacConkey‘s agar medium, were seen as large pink and mucoid 
colonies. 
3.4.2 Microscopical Examination:   
With Grams staining technique, Gram-negative capsulated rods were 
seen. 
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3.4.3 Biochemical Reaction: 
All isolates were lactose fermenting with acid and gas production 
Most of them ferment glucose and sucrose with acid or gas 
production. 
All isolates were Indole-negative, Methyl red-positive, and Voges -
Proskauer negative. Almost all of them were Citrate-positive. 
Klebsiella Pneumoniae gives a positive urease test after 18-24 hours 
and positive citrate. 
3.5 Identification of Proteus vulgaris 
3.5.1 Cultural Characteristics: 
On nutrient agar , fishy smell and swarming appearance, was seen 
On MacConky‘s agar and deoxycholate citrate agar, pale coloured 
colonies were observed as a sign of non lactose ferment and with no 
swarming.  
3.5.2 Microscopical Examination: 
With Gram’s staining technique, Gram- negative was seen. 
3.5.3 Biochemical reactions: 
All isolates were non lactose fomenters. Most of the isolates 
fermented sucrose with acid production and some of them formed gas 
.All isolates fermented glucose with acid production. 
Most of isolates were Methyl red positive, and all of them were 
Voges -Proskauer negative. Almost all of them were urease positive. 
All isolates changed the colour of slope of K.I.A from yellow to 
red and maintained the yellow colour of butt. Most were H2S producers 
and gas non- producers. 
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3.6 Susceptibility Test: 
The interpretation of the inhibition zone diameters was based on the 
following data (NCCLS). 
Table 6: 
Activity of 
Antibiotic 
Activity of Antibiotics 
 Ceftazidime Cefoperazone Cefotaxime Ceftriaxone
Resistant ≤ 14mm ≤ 14mm ≤ 14mm ≤ 13mm 
Sensitive ≥ 18mm ≥ 23mm ≥ 21mm ≥ 21mm 
Intermediate 15 – 17mm 15 – 22mm 15 – 20mm 14 – 20mm 
 
3.7 Quality Control: 
 Diameters of zone of inhibition (mm) obtained from susceptibility 
testing of organism’s standard strains against antimicrobials of the study 
which agreed with that on Nccls and that emphasized the validity of the 
antimicrobial disc 
Table 7: Quality Control:  
Name of 
Organisms 
Zone of Inhibition 
 Ceftazidime Cefoperazone Cefotaxime Ceftriaxone 
Staph aureus ـــــــ  26 27 25 
Pseudomonas 
aeruginosa 
26 23 21 22 
Escherichia coli 30 29 32 33 
Proteus vulgarise 25 27 25 30 
Klebsiella 
pneumonia 
23 25 30 33 
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Table8: Diameter of Zones Inhibition of Antimicrobial (mm) Against 
Staph aureus 
Zone of Inhibition Isolate 
Code Ceftazidime Cefotaxime Cefoperazone Ceftriaxone 
1 S 18 (S) 22 (S) 21 (S) 14 (R) 
2 S 14 (R) 14 (R) 21 (S) 14 (R) 
3 S 15 (I) 14 (R) 10 (R) 23 (S) 
4 S 14 (R) 21 (S) 26 (S) 15 (I) 
5 S 00 (R) 00 (R) 21 (S) 23 (S) 
6 S 20 (S) 00 (R) 10 (R) 23 (S) 
7 S 22 (S) 00 (R) 15 (I) 23 (S) 
8 S 00 (R) 26 (S) 00 (R) 23 (S) 
9 S 11 (R) 00 (R) 22 (S) 14 (R) 
10 S 14 (R) 00 (R) 18 (I) 14 (R) 
11 S 13 (R) 11 (R) 14 (I) 15 (I) 
12 S 13 (R) 12 (R) 16 (I) 25 (S) 
13 S 22 (S) 25 (S) 22 (S) 23 (S) 
14 S 00 (R) 25 (S) 11 (R) 12 (R) 
15 S 12 (R) 14 (R) 21 (S) 12 (R) 
16 S 15 (I) 16 (I) 16 (I) 23 (S) 
17 S 17 (I) 16 (I) 16 (I) 15 (I) 
18 S 15 (I) 14 (R) 13 (R) 13 (R) 
19 S 14 (I) 23 (S) 27 (S) 14 (R) 
20 S 00 (R) 23 (S) 28 (S) 16 (I) 
21 S 16 (I) 23 (S) 21 (S) 14 (R) 
22 S 00 (R) 13 (R) 13 (R) 17 (I) 
23 S 13 (R) 12 (R) 13 (R) 26 (S) 
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Zone of Inhibition Isolate 
Code Ceftazidime Cefotaxime Cefoperazone Ceftriaxone 
24 S 16 (I) 12 (R) 23 (S) 26 (S) 
25 S 14 (R) 21 (S) 8 (R) 26 (S) 
26 S 16 (I) 12 (R) 21 (S) 23 (S) 
27 S 13 (R) 10 (R) 10 (R) 15 (I) 
28 S 15 (I) 21 (S) 26 (S) 00 (R) 
29 S 12 (R) 15 (I) 10 (R) 15 (I) 
30 S 14 (R) 15 (I)  26 (S) 00 (R) 
31 S 19 (S) 23 (S) 25 (S) 00 (R) 
32 S 26 (S) 14 (R) 28 (S) 26 (S) 
33 S 11 (R) 21 (S) 12 (R) 23 (S) 
34 S 10 (R) 13 (R) 10 (R) 28 (S) 
35 S 00 (R) 22 (S) 15 (I) 00 (R) 
36 S 14 (R) 13 (R) 15 (I) 11 (R) 
37 S 00 (R) 20 (I) 12 (R) 00 (R) 
38 S 12 (R) 00 (R) 21 (S) 14 (R) 
39 S 12 (R) 24 (S) 20 (I) 28 (S) 
40 S 00 (R) 00 (R) 21 (S) 14 (R) 
41 S 00 (R) 15 (I) 12 (R) 10 (R) 
42 S 22 (S) 13 (R) 24 (S) 14 (R) 
43 S 13 (R) 21 (S) 12 (R) 12 (R) 
44 S 13 (R) 13 (R) 24 (S) 12 (R) 
45 S 13 (R) 13 (R) 12 (R) 11 (R) 
46 S 11 (R) 17 (I) 24 (S) 13 (I) 
47 S 00 (R) 10 (R) 21 (S) 14 (R) 
48 S 00 (R) 10 (R) 11 (R) 14 (R) 
49 S 00 (R) 23 (S) 9 (R) 13 (I) 
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Zone of Inhibition Isolate 
Code Ceftazidime Cefotaxime Cefoperazone Ceftriaxone 
50 S 00 (R) 13 (R) 22 (S) 23 (S) 
51 S 00 (R) 13 (R) 9 (R) 26 (S) 
52 S 14 (R) 22 (S) 22 (S) 23 (S) 
53 S 12 (R) 00 (R) 13 (R) 28 (S) 
54 S 00 (R) 00 (R) 13 (R) 24 (S) 
55 S 00 (R) 00 (R) 20 (I) 24 (S) 
 
Key: 
 S:  Sensitive 
 R: Resistant  
           I: Intermediate 
 
Table 9: Susceptibility of Staph aureus n (55) to  
Activity of Antibiotics Activity of 
Antibiotic Ceftazidime Cefoperazone Cefotaxime Ceftriaxone 
Resistant 40 (73%) 31 (56%) 20 (36%) 24 (44%) 
Sensitive 7 (13%) 17 (31%) 24 (44%) 22 (40%) 
Intermediate 8 (14%) 7 (13%) 11 (20%) 9 (16%) 
Total 55 (100%) 55 (100%) 55 (100%) 55 (100%) 
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Figure (1): Susceptibility of Staph aureus   n (55) to Ceftazidime, Cefoperazone,  Cefotaxime & 
Ceftriaxone
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Table 10: Diameter of zones inhibition of antimicrobial (mm) 
against Proteus Vulgaris 
Zone of inhibition 
Isolate 
Code Ceftazidime Cefotaxime Cefoperazon
e 
Ceftriaxone 
1 Pr 18 (S) 00 (R) 22 (S) 18 (I) 
2 Pr 18 (S) 13 (R) 21 (S) 00 (R) 
3 Pr 20 (S) 10 (R) 24 (S) 12 (R) 
4 Pr 14 (R) 00 (R) 26 (S) 13 (R) 
5 Pr 22 (S) 14 (R) 24 (S) 22 (S) 
6 Pr 22 (S) 00 (R) 00 (R) 15 (I) 
7 Pr 13 (R) 16 (I) 16 (I) 26 (S) 
8 Pr 23 (S) 24 (S) 13 (R) 28 (S) 
9 Pr 23 (S) 24 (S) 29 (S) 30 (S) 
10 Pr 19 (S) 13 (R) 12 (R) 25 (S) 
11 Pr 18 (S) 11 (R) 00 (R) 12 (R) 
12 Pr 22 (S) 11 (R) 25 (S) 00 (R) 
13 Pr 21 (S) 12 (R) 11 (R) 13 (R) 
14 Pr 12 (R) 15 (I) 24 (S) 14 (I) 
15 Pr 17 (I) 26 (S) 28 (S) 32 (S) 
16 Pr 17 (I) 25 (S) 00 (R) 16 (I) 
17 Pr 22 (S) 00 (R) 10 (R) 24 (S) 
18 Pr 22 (S) 11 (R) 00 (R) 20 (I) 
19 Pr 16 (I) 18 (I) 25 (S) 23 (S) 
20 Pr 11 (R) 13 (R) 14 (R) 00 (R) 
21 Pr 11 (R) 26 (S) 21 (S) 10 (R) 
22 Pr 16 (I) 00 (R) 11 (R) 11 (R) 
23 Pr 20 (S) 19 (I) 29 (S) 00 (R) 
24 Pr 22 (S) 10 (R) 25 (S) 00 (R) 
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25 Pr 20 (S) 23 (S) 24 (S) 10 (R) 
Key: 
S: Sensitive 
R: Resistant  
I: Intermediate  
Table 11: Susceptibility of Proteus Vulgaris n (25) to 
Activity of Antibiotic 
Activity of 
Antibiotic Ceftazidim
e 
Cefoperazo
ne  
Cefotaxim
e 
Ceftriaxon
e 
Resistance 5 (20%) 10 (40%) 15 (60%) 12 (48%) 
Sensitive 16 (64%) 14 (56%) 6 (24%) 8 (32%) 
Intermediat
e 
4 (16%) 1 (4%) 4 (16%) 5 (20%) 
Total 25 (100%) 25 (100%) 25 (100%) 25 (100%) 
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Figure (2):Susceptibility of Pr   n (25) to Ceftazidime, Cefoperazone,  Cefotaxime & Ceftriaxone
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Table 12: Diameter of zones inhibition of antimicrobial (mm) 
against Klebsiella Pneumoniae  
Zone of Inhibition 
Isolate 
Code Cefitazidime Cefotaxime Cefoperazon
e 
Ceftriaxone 
1 K 18 (S) 14 (R) 22 (S) 16 (I) 
2 K 18 (S) 12 (R) 26 (S) 14 (I) 
3 K 20 (S) 00 (R) 24 (S) 22 (S) 
4 K 22 (S) 00 (R) 13 (R) 26 (S) 
5 K 23 (R) 11 (R) 00 (R) 26 (S) 
6 K 17 (I) 10 (R) 11 (R) 23 (S) 
7 K 15 (I) 9 (R) 32 (S) 00 (R) 
8 K 18 (S) 25 (S) 30 (S) 12 (R) 
9 K 20 (S) 24 (S) 15 (I) 18 (I) 
10 K 21 (S) 30 (S) 24 (S) 29 (S) 
Isolate 
Code Zone of Inhibition 
 Cefitazidime Cefotaxime Cefoperazon
e 
Ceftriaxone 
12 K 11 (R) 13 (R) 22 (S) 25 (S) 
13 K 19 (S) 33 (S) 22 (S) 11 (R) 
14 K 22 (S) 30 (S) 00 (R) 10 (R) 
15 K 20 (S) 00 (R) 23 (S) 00 (R) 
16 K 18 (S) 8 (R) 18 (I) 28 (S) 
17 K 22 (S) 29 (S) 23 (S) 26 (S) 
18 K 19 (S) 20 (I) 22 (S) 8 (R) 
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19 K 19 (S) 18 (I) 30 (S) 30 (S) 
20 K 21 (S) 24 (S) 00 (R) 30 (S) 
 
Key: 
S: Sensitive 
R: Resistant  
I: Intermediate 
 
Table 13: Susceptibility of Klebsiella Pneumoniae n (20) to 
Activity of Antibiotic Activity of 
Antibiotic 
Ceftazidim
e 
Cefoperazo
ne  
Cefotaxim
e 
Ceftriaxon
e 
Resistance 3 (15%) 5 (25%) 10 (50%) 6 (30%) 
Sensitive 15 (75%) 13 (65%) 7 (35%) 11 (55%) 
Intermediat
e  
2 (10%) 2 (10%) 3 (15%) 3 (15%) 
Total 20 (100%) 20 (100%) 20 (100%) 20 (100%) 
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Figure (3): Susceptibility of Kleb   n (20) to Ceftazidime, Cefoperazone,  Cefotaxime & 
Ceftriaxone
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Table 14: Diameter of zones inhibition of antimicrobial (mm) 
against Escherichia Coli  
 
Zone of Inhibition Isolat
e 
Code 
Ceftazidim
e 
Cefotaxim
e 
Cefoperazon
e 
Ceftriaxon
e 
1 E 22 (S)  13 (R) 23 (S) 22 (S) 
2 E 20 (S) 12 (R) 21 (S) 25 (S) 
3 E 13 (R) 13 (R) 21 (S) 23 (S) 
4 E 13 (R) 29 (S) 22 (S) 00 (R) 
5 E 20 (S) 14 (R) 25 (S) 00 (R) 
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6 E 21 (S) 00 (R) 15 (I) 11 (R) 
7 E 18 (S) 24 (S) 28 (S) 13 (R) 
8 E 19 (S) 15 (I) 00 (R) 00 (R) 
9 E 19 (S) 11 (R) 11 (R) 14 (I) 
10 E 12 (R) 00 (R) 14 (R) 14 (I) 
11 E 22 (S) 12 (R) 12 (R) 29 (S) 
12 E 16 (I) 12 (R) 00 (R) 27 (S) 
13 E 15 (I) 23 (S) 29 (S) 25 (S) 
14 E 10 (R) 15 (I) 28 (S) 28 (S) 
15 E 22 (S) 29 (S) 29 (S) 26 (S) 
16 E 20 (S) 13 (R) 18 (I) 16 (I) 
17 E 15 (I) 14 (R) 25 (S) 24 (S) 
18 E 11 (R) 11 (R) 00 (R) 22 (S) 
19 E 20 (S) 26 (S) 24 (S) 22 (S) 
20 E 11 (R) 00 (R) 26 (S) 11 (R) 
21 E 21 (S) 27 (S) 10 (R) 29 (S) 
22 E 14 (R) 00 (R) 22 (S) 27 (S) 
23 E 18 (S) 00 (R) 24 (S) 26 (S) 
 
 
 
Zone of Inhibition Isolat
e 
Code Ceftazidim
e 
Cefotaxim
e 
Cefoperazon
e 
Ceftriaxon
e 
24 E 18 (S) 12 (R) 23 (S) 24 (S) 
25 E 19 (S) 15 (I) 21 (S) 00 (R) 
26 E 19 (S) 28 (S) 21 (S) 00 (R) 
72 
 
27 E 19 (S) 11 (R) 00 (R) 12 (R) 
28 E 20 (S) 20 (I) 11 (R) 10 (R) 
 
Key: 
S: Sensitive 
R: Resistant  
I: Intermediate 
  
Table 15: Susceptibility of E-coli n (28) to  
 
Activity of Antibiotic Activity of 
Antibiotic 
Ceftazidim
e 
Cefoperazon
e  
Cefotaxim
e 
Ceftriaxon
e 
Resistance 7 (25%) 9 (32%) 17 (61%) 10 (36%) 
Sensitive 18 (64%) 17 (61%) 7 (25%) 15 (53%) 
Intermediat
e 
3 (11%) 2 (7%) 4 (14%) 3 (11%) 
Total 28 (100%) 28 (100%) 28 (100%) 28 (100%) 
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Figure (4): Susceptibility of E-coli   n (28) to Ceftazidime, Cefoperazone,  Cefotaxime & 
Ceftriaxone 
Resistance 
Sensitive 
Intermediate 
 
Table 16: Diameters of zone inhibition of antimicrobial (mm) 
against Pseudomonase aeruginosa 
Zone of Inhibition (mm) Isolat
e 
Code 
Ceftazidim
e 
Cefotaxim
e 
Cefoperazon
e 
Ceftriaxon
e 
1 Ps 20 (S) 00 (R) 15 (I) 00 (R) 
2 Ps 26 (S) 00 (R) 12 (R) 00 (R) 
3 Ps 27 (S) 18 (I) 23 (S) 00 (R) 
4 Ps 26 (S) 18 (I) 23 (S) 00 (R) 
5 Ps 23 (S) 18 (I) 23 (S) 00 (R) 
6 Ps 19 (S) 00 (R) 10 (R) 00 (R) 
7 Ps 22 (S) 00 (R) 00 (R) 00 (R) 
8 Ps 27 (S) 19 (I) 24 (S) 00 (R) 
9 Ps 27 (S) 18 (I) 24 (S) 18 (I) 
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10 Ps 24 (S) 18 (I) 23 (S) 00 (R) 
11 Ps 27 (S) 18 (I) 24 (S) 18 (I) 
12 Ps 26 (S) 17 (I) 22 (S) 00 (R) 
13 Ps 24 (S) 00 (R) 00 (R) 00 (R) 
14 Ps 23 (S) 18 (I) 24 (S) 18 (I) 
15 Ps 25 (S) 00 (R) 00 (R) 00 (R) 
16 Ps 28 (S) 18 (I) 23 (S) 00 (R) 
17 Ps 25 (S) 18 (I) 21 (S) 00 (R) 
18 Ps 23 (S) 00 (R) 00 (R) 12 (R) 
19 Ps 27 (S) 17 (I) 24 (S) 18 (I) 
20 Ps 27 (S) 18 (I) 22 (S) 18 (I) 
21 Ps 24 (S) 17 (I) 23 (S) 00 (R) 
22 Ps 13 (R) 00 (R) 00 (R) 00 (R) 
23 Ps 22 (S) 13 (R) 18 (I) 18 (I) 
 
Zone of Inhibition (mm) Isolat
e 
Code 
Cefitazidim
e 
Cefotaxim
e 
Cefoperazon
e 
Ceftriaxon
e 
24 Ps 26 (S) 17 (I) 24 (S) 17 (I) 
25 Ps 25 (S) 15 (I) 21 (S) 00 (R) 
26 Ps 24 (S) 13 (R) 21 (S) 18 (I) 
27 Ps 20 (S) 13 (R) 18 (I) 00 (R) 
28 Ps 23 (S) 00 (R) 21 (S) 00 (R) 
29 Ps 24 (S) 15 (I) 21 (S) 21 (S) 
30 Ps 20 (S) 15 (I) 18 (I) 16 (S) 
31 Ps 23 (S) 18 (I) 21 (S) 15 (I) 
32 Ps 22 (S) 00 (R) 00 (R) 00 (R) 
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33 Ps 22 (S) 00 (R) 00 (R) 00 (R) 
34 Ps 13 (R) 13 (R) 17 (R) 00 (R) 
35 Ps 19 (S) 00 (R) 22 (S) 00 (R) 
36 Ps 25 (S) 15 (I) 22 (S) 17 (I) 
37 Ps 22 (S) 12 (R) 16 (I) 00 (R) 
38 Ps 21 (S) 15 (I) 18 (I) 18 (I) 
39 Ps 21 (S) 00 (R) 24 (S) 00 (R) 
40 Ps 23 (S) 12 (R) 16 (I) 23 (S) 
41 Ps 20 (S) 00 (R) 18 (I) 00 (R) 
42 Ps 15 (R) 15 (I) 00 (R) 17 (I) 
43 Ps 21 (S) 12 (R) 22 (S) 00 (R) 
44 Ps 12 (R) 17 (I) 16 (I) 00 (R) 
45 Ps 13 (R) 15 (I) 18 (I) 00 (R) 
Key: 
S: Sensitive 
R: Resistant  
I: Intermediate  
Table 17: Susceptibility of Ps  n (45) to 
Activity of antibiotic Activity of 
antibiotic 
Ceftazidim
e 
Cefotaxim
e 
Cefoperazo
ne 
Ceftriaxon
e 
Resistance 5 (11%) 21 (47%) 11 (25%) 29 (64%) 
Sensitive 40 (89%) - 24 (53%) 4 (9%) 
Intermediat
e 
00 (00%) 24 (53%) 10 (22%) 12 (27%) 
Total 45 (100%) 45 (100%) 45 (100%) 45 (100%) 
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Figure (5): Susceptibility of Ps   n (45) to Cefitazidime, Cefotaxime, Cefoperazone & Ceftriaxone
Resistance 
Sensitive 
Intermediate 
 
 
 
 
 
Chapter Four 
Discussion      
 Most wound infection probably comes from the patient or personal 
through direct contact during the operation or later in recovery rooms or 
wards. 
      This study was conducted to isolate clinical specimens recovered 
from infected wound and to test invitro activities of four members of the 
third generation cephalosporins (Cefitazime, Cefoperazone, cefotaxime 
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and Ceftriaxone) were evaluated using 173 isolates of bacteria by Kirby 
Bauer disc diffusion method, judged by criteria of National Committee 
for Clinical Laboratory Standard. 
         The common causative bacterial gents of wound infections are 
staphylococci (55 of all wound infections). 
         This result is in alignment with most clinical studies from wound 
swab in Sudan that showed predominant presence of Staphylococcus 
aureus. Elegail, 1994 found that in wound infection, Staph .aureus 
contributes to 52% of the total samples collected. 
       The rate of resistance among Staph aureus 40 (73%) to Cefitazidime, 
while the resistance of these isolates to cefoperazone was found 31 
(65%). 
      The other two antibiotics Ceftriaxone 24(44%) and cefotaxime 20 
(36%) are less resistance respectively. These results confirm the finding 
of Bonomo (2003). 
       The tested isolates 16 (64%) were sensitive to Cefitazidime. The 
other antibiotics cefoperazone 14 (56%), ceftriaxone 8 (32%) and 
cefotaxime 6 (24%) were less active on Proteus Vulgaris, similar result 
by Onche and Adedgi (2004). 
      The total number of Klebsiella Pneumoniae isolates was 20, 15 (75%) 
were sensitive Cefitazidime. While sensitivity of these isolates to 
cefoperazone 13 (65%). the other two antibiotics Ceftriaxone 11(55%) 
and cefotaxime 7 (35%) where less active, these result confirm the 
finding of Onche and Adedgi (2004).  
         Escherichia coli is sensitive to Ceftazidime 18 (64%), also sensitive 
to cefoperazone 17 (61%), were less active to ceftriaxone 15(53%) and 
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cefotaxime 7 (25%). This result near to that obtained by Leonid et al., 
1998. 
       Of the tested isolates 40 (89%) were sensitive to Ceftazidime.While 
sensitivity of this isolates to cefoperazone was found 24(53%).  
      The other two antibiotics ceftriaxone and cefotaxime where less 
active on Pseudomonase aeruginosa, their actives were 4(9%) and 00 
(00%) respectively. 
       These results confirm the finding of Massad (2005) who studied the 
activity of Ceftazidime on Ps.aeruginosa as (87%) similar result (89%) 
and (89%) obtained else where (Kachrid and Ben Hassan, 2000 and 
Qadri, et al., 1991) respectively.   
          The activity of cefoperazone in the present study was found similar 
to the result obtained by Sarver, et al.,(1981) and Lee et al., (1990). 
        On the other hand, our finding of cefotaxime agrees with those of 
Bonomo (2003) who reported that cefotaxime was 47%. This result was 
significantly different from that obtained by Tayseer (1997). Moreover, 
Watankunakorn (1983) reported that the majority of Ps.aeruginosa 
resistance to cefotaxime. 
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Zone of Inhibition Isolate code 
Ceftazidime Cefotaxime Cefoperazone Ceftriaxone 
1 Pr 18 (S) 00 (R) 22 (S) 18 (I) 
2 Pr 18 (S) 13 (R) 21 (S) 00 (R) 
3 Pr 20 (S) 10 (R) 24 (S) 12 (R) 
4 Pr 14 (R) 00 (R) 26 (S) 13 (R) 
5 Pr 22 (S) 14 (R) 24 (S) 22 (S) 
6 Pr 22 (S) 00 (R) 00 (R) 15 (I) 
7 Pr 13 (R) 16 (I) 16 (I) 26 (S) 
8 Pr 23 (S) 24 (S) 13 (R) 28 (S) 
9 Pr 23 (S) 24 (S) 29 (S) 30 (S) 
10pr 19 (S) 13 (R) 12 (R) 25 (S) 
11 Pr 18 (S) 11 (R) 00 (R) 12 (R) 
12 Pr 22 (S) 11 (R) 25 (S) 00 (R) 
13 Pr 21 (S) 12 (R) 11 (R) 13 (R) 
14 Pr 12 (R) 15 (I) 24 (S) 14 (I) 
15 Pr 17 (I) 26 (S) 28 (S) 32 (S) 
16 Pr 17 (I) 25 (S) 00 (R) 16 (I) 
17 Pr 22 (S) 00 (R) 10 (R) 24 (S) 
18 Pr 22 (S) 11 (R) 00 (R) 20 (I) 
19 Pr 16 (I) 18 (I) 25 (S) 23 (S) 
20 Pr 11 (R) 13 (R) 14 (R) 00 (R) 
21 Pr 11 (R) 26 (S) 21 (S) 10 (R) 
22 Pr 16 (I) 00 (R) 11 (R) 11 (R) 
23 Pr 20 (S) 19 (I) 29 (S) 00 (R) 
24 Pr 22 (S) 10 (R) 25 (S) 00 (R) 
25 Pr 20 (S) 23 (S) 24 (S) 10 (R) 
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Figure (2):Susceptibility of Pr   n (25) to Ceftazidime, Cefoperazone,  Cefotaxime & Ceftriaxone
Resistance 
Sensitive 
Intermediate 
Key: 
S: Sensitive 
R: Resistant   
I: Intermediate  
 
Table 11: Susceptibility of Proteus vulgaris n (25) to 
Activity of Antibiotics Activity of 
Antibiotic 
Ceftazidime Cefoperazone Cefotaxime Ceftriaxone 
Resistant 5 (20%) 10 (40%) 15 (60%) 12 (48%) 
Sensitive 16 (64%) 14 (56%) 6 (24%) 8 (32%) 
Intermediate 4 (16%) 1 (4%) 4 (16%) 5 (20%) 
Total 25 (100%) 25 (100%) 25 (100%) 25 (100%) 
